Literature DB >> 12770499

Cloning and expression of the ccdA-associated thiol-disulfide oxidoreductase (catA) gene from Brevibacillus choshinensis: stimulation of human epidermal growth factor production.

Ryoichi Tanaka1, Makoto Mizukami, Matsujiro Ishibashi, Hiroko Tokunaga, Masao Tokunaga.   

Abstract

Brevibacillus choshinensis (Bacillus brevis) is a protein-hyperproducing bacterium with a useful host-vector system for the production of recombinant proteins. Here, we cloned the ccdA-catA (cmacr;cdA āssociated thioredoxin-like tmacr;hiol-disulfide oxidoreductase) locus of B. choshinensis HPD31-S5. CatA protein (molecular weight, 19664) contains a thioredoxin-like motif, Cys-Gly-Pro-Cys. It was successfully expressed in B. choshinensis extracellularly ( approximately 100 microg x ml(-1) culture) using the secretion vector pNCMO2, and in Escherichia coli intracellularly ( approximately 350 microg x ml(-1) culture) with an amino-terminal His-tag. Both recombinant proteins showed thiol-disulfide oxidoreductase activity. Incubation of non-native human epidermal growth factor (hEGF) containing incorrect disulfide bonds with B. choshinensis cells secreting CatA protein resulted in the stimulation of the conversion of non-native hEGF to the native form. Furthermore, co-expression of CatA protein with recombinant hEGF in the B. choshinensis production system increased the yield of native hEGF.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12770499     DOI: 10.1016/s0168-1656(03)00071-3

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  2 in total

1.  Functional expression of recombinant human trefoil factor 1 by Escherichia coli and Brevibacillus choshinensis.

Authors:  Yueh-Mei Cheng; Meng-Ting Lu; Chuan Mei Yeh
Journal:  BMC Biotechnol       Date:  2015-05-20       Impact factor: 2.563

Review 2.  Applications of thiol-disulfide oxidoreductases for optimized in vivo production of functionally active proteins in Bacillus.

Authors:  Thijs R H M Kouwen; Jan Maarten van Dijl
Journal:  Appl Microbiol Biotechnol       Date:  2009-11       Impact factor: 4.813

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.